Sugi Predict

Sugi Predict / Compounds / SCHEMBL6584103

SCHEMBL6584103

SCHEMBL6584103

COc1cc2c(C)n[nH]c(=O)c2cc1OC1CCCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4B Q07343 15/20 0.47
▸ PDE4A P27815 13/20 0.47
▸ PDE4C Q08493 13/20 0.47
▸ PDE4D Q08499 13/20 0.47
▸ ALDH1A1 P00352 3/20 0.42
▸ CYP3A4 P08684 2/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ ALOX15 P16050 2/20 0.42
▸ MAPK1 P28482 2/20 0.42
▸ VEGFA P15692 1/20 0.42
▸ LMNA P02545 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ MAPT P10636 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CREBBP Q92793 1/20 0.42
▸ PDE5A O76074 1/20 0.42
▸ TNF P01375 1/20 0.42
▸ BLM P54132 1/20 0.42
▸ PDE1A P54750 1/20 0.42
▸ PDE1B Q01064 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11546262 0.84 PDE4A (0.49) PDE4BPDE4APDE4CPDE4DALDH1A1
SCHEMBL6586411 0.84 PDE4B (0.54) PDE4BPDE4APDE4CPDE4DCYP3A4
SCHEMBL6584311 0.78 PDE4A (0.47) PDE4BPDE4APDE4CPDE4DALDH1A1
SCHEMBL26604602 0.75 PDE3A (0.43) PDE4BPDE4APDE4CPDE4DALDH1A1
SCHEMBL6590560 0.73 PDE4A (0.64) PDE4BPDE4APDE4CPDE4DLMNA
Hydrochloric Acid SCHEMBL27987997 0.72 SRC (0.48) PDE4BPDE4APDE4CPDE4DTLR9
SCHEMBL26123965 0.71 PRMT5 (0.46) —
SCHEMBL29059331 0.71 PDE4D (0.45) PDE4BPDE4APDE4CPDE4D
SCHEMBL29059335 0.71 PDE4D (0.45) PDE4BPDE4APDE4CPDE4D
SCHEMBL30544697 0.71 PDE4D (0.45) PDE4BPDE4APDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040043999-A1 Phthalazine derivatives as phosphodiesterase 4-inhibitors ZAMBON GROUP S.P.A 2004-03-04 — — US disclosed
EP-1042300-B1 PHTHALAZINE DERIVATIVES USEFUL AS PHOSPHODIESTERASE 4 INHIBITORS ZAMBON SPA (IT) 2004-02-11 — — EP disclosed
US-6589951-B1 N right-arrowO derivatives and pharmaceutically acceptable salt thereof are PDE 4 and TNF pharmaceutically acceptable salt thereof are PDE 4 and TNF alpha inhibitors. ZAMBON GROUP S.P.A. (IT) 2003-07-08 — — US disclosed
EP-1042300-A1 PHTHALAZINE DERIVATIVES PHOSPHODIESTERASE 4 INHIBITORS ZAMBON GROUP S.p.A. (IT) 2000-10-11 — — EP disclosed
WO-1999032456-A1 PHTHALAZINE DERIVATIVES PHOSPHODIESTERASE 4 INHIBITORS ZAMBON GROUP S.P.A. (IT) 1999-07-01 — — WO disclosed
WO-1998025948-A9 PROCESSES FOR PREPARATION OF 9,11-EPOXY STEROIDS AND INTERMEDIATES USEFUL THEREIN — 1998-11-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040043999-A1 Phthalazine derivatives as phosphodiesterase 4-inhibitors PDE5A, PDE3B, PDE3A PDE4B 9/4885PDE4A 7/4885PDE4C 17/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.